Etanercept is safely used for treating psoriatic arthritis in a patient complicated with type 1 hereditary angioedema

Noriko UmegakiDepartment of Dermatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan

Masahiro KiraDepartment of Dermatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, JapanCorrespondence[email protected]

Takahiko HoriuchiDepartment of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan

Saori ItoiDepartment of Dermatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan

Mamori TaniDepartment of Dermatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan

Akinori YokomiDepartment of Dermatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan

Atsushi TanemuraDepartment of Dermatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan

Hisaaki MiyaharaNHO Kyushu Medical Center, Fukuoka, Japan

Michiyo HatanakaDepartment of Medical Technology, Faculty of Health Sciences, Kobe Tokiwa University, Kobe, Japan

Hajime KitamuraDepartment of Medical Technology, Faculty of Health Sciences, Kobe Tokiwa University, Kobe, Japan

Etsuko KitanoDepartment of Medical Technology, Faculty of Health Sciences, Kobe Tokiwa University, Kobe, Japan

Ichiro KatayamaDepartment of Dermatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan

show all

Abstract

Hereditary angioedema (HAE) is a life-threatening disorder caused by deficiency or dysfunction of the C1 inhibitor protein. Patients with HAE are restricted in various medical treatments, which can induce an HAE attack. We herein report the first case of psoriatic arthritis (PSA) with type 1 HAE successfully treated with 25 mg of etanercept without HAE attack. Etanercept may represent a useful choice for treating patients with HAE accompanied by intractable PSA and rheumatoid arthritis (RA).

Keywords::

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Etanercept is safely used for treating psoriatic arthritis in a patient complicated with type 1 hereditary angioedema

Information for

Open access

Opportunities

Help and information

Etanercept is safely used for treating psoriatic arthritis in a patient complicated with type 1 hereditary angioedema

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature